<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: TROP-2 is a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-promoting molecule that has been found to be overexpressed in many <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, making it a plausible biomarker of <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The main aim of this study was to examine the effect of green tea <z:chebi fb="0" ids="23053">catechins</z:chebi> (namely, <z:chebi fb="0" ids="4806">(-)-epigallocatechin-3-gallate</z:chebi>; <z:chebi fb="0" ids="4806">EGCG</z:chebi>) on TROP-2 expression </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: Western blot and RT-PCR were applied to assess TROP2 expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells and tissues </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Two different mechanisms were found to operate in diverse cell lines </plain></SENT>
<SENT sid="4" pm="."><plain>In SW480 cells, <z:chebi fb="0" ids="4806">EGCG</z:chebi> affected the post-transcriptional processing of the TROP-2 mRNA, as this was quickly and specifically degraded in the presence of <z:chebi fb="0" ids="4806">EGCG</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>In HCT-116 cells, <z:chebi fb="0" ids="4806">EGCG</z:chebi> affected TROP-2 expression at the post-translational level </plain></SENT>
<SENT sid="6" pm="."><plain>TROP-2 was found to be highly expressed in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> compared to adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: This study provided a novel beneficial activity of green tea as an anti-tumorigenagent causing the suppression of TROP-2 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>